Market Value18,809,854,000
Total Holdings99
File Date2020-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
VYNE / VYNE Therapeutics Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
CTMX / CytomX Therapeutics, Inc.
NLTX / Neoleukin Therapeutics, Inc.
CBAY / CymaBay Therapeutics, Inc.
SYRS / Syros Pharmaceuticals, Inc.
ABEO / Abeona Therapeutics Inc.
CYCN / Cyclerion Therapeutics, Inc.
US0153511094 / Alexion Pharmaceuticals, Inc.
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
AQST / Aquestive Therapeutics, Inc.
GWP / GW Pharmaceuticals plc
CERS / Cerus Corporation
RETA / Reata Pharmaceuticals Inc - Class A
ARGX / argenx SE - Depositary Receipt (Common Stock)
ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
EXAS / Exact Sciences Corporation
DOVA / Dova Pharmaceuticals, Inc.
XBIT / XBiotech Inc.
US62857M1053 / MyoKardia, Inc.
HARP / Harpoon Therapeutics, Inc.
ONCE / Spark Therapeutics, Inc.
MIST / Milestone Pharmaceuticals Inc.
FTSV / Forty Seven, Inc.
BOLD / Boundless Bio, Inc.
US64125CAD11 / Neurocrine Bios Bond
YMAB / Y-mAbs Therapeutics, Inc.
GTHX / G1 Therapeutics, Inc.
US74257L1089 / Principia Biopharma Inc.
FSTX / F-star Therapeutics Inc
ADPT / Adaptive Biotechnologies Corporation
MDGL / Madrigal Pharmaceuticals, Inc.
MIRM / Mirum Pharmaceuticals, Inc.
US00448Q2012 / Achillion Pharmaceuticals, Inc.
INSM / Insmed Incorporated
KOD / Kodiak Sciences Inc.
AGLE / Aeglea BioTherapeutics Inc
KRYS / Krystal Biotech, Inc.
IDRA / Idera Pharmaceuticals, Inc.
GHDX / Genomic Health, Inc.
FOMX / Foamix Pharmaceuticals Ltd.
CPRX / Catalyst Pharmaceuticals, Inc.
QLGN / Qualigen Therapeutics, Inc.
TRIL / Trillium Therapeutics Inc
SGMO / Sangamo Therapeutics, Inc.
ALBO / Albireo Pharma Inc
HALO / Halozyme Therapeutics, Inc.
XNCR / Xencor, Inc.
ZYME / Zymeworks Inc.
CABA / Cabaletta Bio, Inc.
URGN / UroGen Pharma Ltd.
US2103731061 / Constellation Pharmaceuticals Inc
US09061GAH48 / BioMarin Pharmaceutical, Inc. Bond
RARX / Ra Pharmaceuticals, Inc.
ACOR / Acorda Therapeutics, Inc.
NXTC / NextCure, Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
UROV / Urovant Sciences Ltd
VIRX / Viracta Therapeutics, Inc.
0HBB / Aimmune Therapeutics Inc
XLRN / Acceleron Pharma Inc
DERM / Journey Medical Corporation
NTLA / Intellia Therapeutics, Inc.
GLMD / Galmed Pharmaceuticals Ltd.
TPST / Tempest Therapeutics, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
FREQ / Frequency Therapeutics Inc
INFI / Infinity Pharmaceuticals Inc.
INCY / Incyte Corporation
RCUS / Arcus Biosciences, Inc.
APLS / Apellis Pharmaceuticals, Inc.
QURE / uniQure N.V.
CCXI / ChemoCentryx Inc
MRKR / Marker Therapeutics, Inc.
MTNB / Matinas BioPharma Holdings, Inc.
AUPH / Aurinia Pharmaceuticals Inc.
ISEE / IVERIC bio Inc
VKTX / Viking Therapeutics, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
TCDA / Tricida Inc
FLGT / Fulgent Genetics, Inc.
MTEM / Molecular Templates, Inc.
LJPC / La Jolla Pharmaceutical Co.
ADMS / Adamas Pharmaceuticals Inc
SRRA / Sierra Oncology Inc
NGM / NGM Biopharmaceuticals, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
ALLK / Allakos Inc.
PTGX / Protagonist Therapeutics, Inc.
BLUE / bluebird bio, Inc.
EVFM / Evofem Biosciences, Inc.
NBIX / Neurocrine Biosciences, Inc.
DVAX / Dynavax Technologies Corporation
CRNX / Crinetics Pharmaceuticals, Inc.
BCEL / Atreca, Inc.
AXSM / Axsome Therapeutics, Inc.
SGEN / Seagen Inc
IDYA / IDEAYA Biosciences, Inc.
IFRX / InflaRx N.V.
ALKS / Alkermes plc
LPTX / Leap Therapeutics, Inc.
BLCM / Bellicum Pharmaceuticals, Inc.
ANAB / AnaptysBio, Inc.
KNSA / Kiniksa Pharmaceuticals, Ltd.
IGMS / IGM Biosciences, Inc.
MRUS / Merus N.V.
BMRN / BioMarin Pharmaceutical Inc.
ASMB / Assembly Biosciences, Inc.
AFMD / Affimed N.V.
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
ARAV / Aravive, Inc.
NVTA / Invitae Corporation
MRTX / Mirati Therapeutics, Inc.
HRTX / Heron Therapeutics, Inc.
HOOK / HOOKIPA Pharma Inc.
ACAD / ACADIA Pharmaceuticals Inc.